Effect of intraoperative autotransfusion use during liver transplantation for hepatocellular carcinoma on recurrence-free survival: comparative study with propensity score matching.

Date publication

septembre 2025

Journal

BJS open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HEYD Bruno

Tous les auteurs :
Boulard P, Maulat C, Cavillon A, Robin F, Dondero F, Salloum C, Turco C, Breheret F, Paradis V, Lim C, Heyd B, Cuellar E, Suc B, Azoulay D, Migueres I, Cauchy F, Muscari F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40924885

Résumé

Intraoperative autotransfusion remains underutilized in high-risk haemorrhagic oncological procedures, particularly in liver transplantation for hepatocellular carcinoma. This is because of the theoretical risk of tumour cell reinfusion and dissemination, potentially leading to reduced recurrence-free survival. The aim of this study was to evaluate the impact of intraoperative autotransfusion on recurrence-free survival during liver transplantation for hepatocellular carcinoma.

Mots clés

Humans, Carcinoma, Hepatocellular, surgery, Liver Transplantation, methods, Liver Neoplasms, surgery, Male, Female, Propensity Score, Retrospective Studies, Middle Aged, Blood Transfusion, Autologous, statistics & numerical data, Aged, Neoplasm Recurrence, Local, France, epidemiology, Adult, Intraoperative Care, methods, Disease-Free Survival

Référence

BJS Open. 2025 09 8;9(5):